COVID-19 News Coverage

DOM In the News

Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.

Axios

UCSF sees increase of asymptomatic COVID-19 cases

Axios |

Bob Wachter was quoted by Axios revealing asymptomatic COVID cases at the University of California, San Francisco have risen from 2% to 5% in the past month. 

ABC News

More than 90% of COVID deaths occurring among elderly adults: CDC

ABC News |

Peter Chin-Hong spoke to ABC News calling for increased efforts at getting vaccines and boosters to seniors. 

The New York Times

5 Unusual Covid Symptoms — and What to Do About Them

New York Times |

Peter Chin-Hong answered questions from the New York Times explaining why some people infected with COVID are experiencing symptoms like hairy tongue or tingling nerves. 

NPR

New VA study finds Paxlovid may cut the risk of long COVID

NPR |

Peter Chin-Hong and Monica Gandhi were quoted in NPR reacting to a study that shows Paxlovid may reduce the risk of developing long COVID.

San Francisco Chronicle

These are now the most common COVID symptoms — depending on your vaccination status

San Francisco Chronicle |

Peter Chin-Hong and Diane Havlir spoke to the San Francisco Chronicle explaining the most common symptoms for the Omicron variant.

NPR

Study finds long COVID can affect your ability to exercise

NPR |

Matt Durstenfeld was interviewed by NPR summarizing his recent study that shows long COVID can dramatically reduce the capacity for physical exercise.

abc news

COVID cases on the rise in Europe could spell trouble for US

ABC News |

Peter Chin-Hong spoke to ABC News saying that rising COVID cases in Europe could signal another surge coming to the U.S. this winter.

The New York Times

The Power of Paxlovid

New York Times |

Bob Wachter spoke to the New York Times lamenting the underuse of Paxlovid to treat COVID patients, advising that the benefits of the drug outweigh the downsides.

Recent DOM Covid-19 Publications

Lessons learned from academic medical centers’ response to the COVID-19 pandemic in partnership with the Navajo Nation

Bongiovanni T, Shamasunder S, Brown W III, Rivera Carpenter C, Pantell M, Ghali B, Harrison, JD. Lessons learned from academic medical centers’ response to the COVID-19 pandemic in partnership with the Navajo Nation. PLoS ONE. 2022 17(4): e0265945. View in: PlosOne


Tenofovir-based PrEP for Covid-19: an untapped opportunity?

DeJong C, Spinelli MA, Okochi H, Gandhi M. Tenofovir-based PrEP for Covid-19: an untapped opportunity? AIDS. 2021 Mar 11. [Epub ahead of print]. doi: 10.1097/QAD.0000000000002877. View in: PubMed


Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19

Durstenfeld MS, Sun K, Ma Y, Rodriguez F, Secemsky EA, Parikh RV, Hsue PY. Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19. AIDS. 2021 Nov 8. [Epub ahead of print]. doi: 10.1097/QAD.0000000000003129.  View in: PubMed


The evolution of a hospital-based Covid-19 vaccination program for inpatients

Freiser D, Roca M, Chung T, Bhakta T, Winston LG, Ortiz GM. The evolution of a hospital-based Covid-19 vaccination program for inpatients. NEJM Catalyst Innovations in Care Delivery. Vol. 3 No. 2. February 2022. doi: 10.1056/CAT.21.0340. View in: NEJM Catalyst


Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines

Kelly JD, Leonard S, Hoggatt KJ, Boscardin WJ, Lum EN, Moss-Vazquez TA, Andino R, Wong JK, Byers A, Bravata DM, Tien PC, Keyhani S. Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines. JAMA.2022 Oct 11;328(14):1427-1437. doi: 10.1001/jama.2022.17985. View in: PubMed


Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study

Kiang MV, Chin ET, Huynh BQ, Chapman LAC, Rodríguez-Barraquer I, Greenhouse B, Rutherford GW, Bibbins-Domingo K, Havlir D, Basu S, Lo NC. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study. Lancet Infect Dis.2021 Mar 22;S1473-3099(21)00134-1. [Epub ahead of print]. doi: 10.1016/S1473-3099(21)00134-1.View in: PubMed


IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: Who, when, and how?

Matthay MA, Luetkemeyer AF. IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: Who, when, and how? JAMA. 2021 Aug 10;326(6):483-485. doi: 10.1001/jama.2021.11121. View in: PubMed


Early clues regarding the pathogenesis of long-COVID

Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol.2022 Apr;43(4):268-270. [Epub ahead of print] doi: 10.1016/ j. it.2022.02.008. View in: PubMed


Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms

Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ. Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms. Clin Infect Dis. 2022 Jun 10;74(11):2083-2084. doi: 10.1093/cid/ciab890. View in: PubMed


Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms

Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518. View in: PubMed


How will Covid-19 transform global health post-pandemic? Defining research and investment opportunities and priorities

Reid M, Abdool-Karim Q, Geng E, Goosby E. How will Covid-19 transform global health post-pandemic? Defining research and investment opportunities and priorities. PLoS Med. 2021 Mar; 18(3):e1003564. eCollection 2021 Mar. doi: 10.1371/journal.pmed.1003564. View in: PubMed


Vaccinated but not protected — living immunocompromised during the pandemic

Ryan L. Vaccinated but not protected — living immunocompromised during the pandemic. JAMA.2021 Jun 22;325(24):2443-2444. doi: 10.1001/jama.2021.9321. View in: PubMed


Differences in post-mRNA vaccination severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus neutralization test response by human immunodeficiency virus (HIV) status and type of vaccine: A matched case-control observational study

Spinelli MA, Peluso MJ, Lynch KL, Yun C, Glidden DV, Henrich TJ, Deeks SG, Gandhi M. Differences in post-mRNA vaccination severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus neutralization test response by human immunodeficiency virus (HIV) status and type of vaccine: A matched case-control observational study. Clin Infect Dis. 2022 Aug 24;75(1):e916-e919. doi: 10.1093/cid/ciab1009. View in: PubMed


Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Suryawanshi RK, Chen IP, Ma T, Syed AM, Brazer N, Saldhi P, Simoneau CR, Ciling A, Khalid MM, Sreekumar B, Chen PY, Kumar GR, Montano M, Gascon R, Tsou CL, Garcia-Knight MA, Sotomayor-Gonzalez A, Servellita V, Gliwa A, Nguyen J, Silva I, Milbes B, Kojima N, Hess V, Shacreaw M, Lopez L, Brobeck M, Turner F, Soveg FW, George AF, Fang X, Maishan M, Matthay M, Morris MK, Wadford D, Hanson C, Greene WC, Andino R, Spraggon L, Roan NR, Chiu CY, Doudna JA, Ott M. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature. 2022 May 18. [Epub ahead of print]. doi: 10.1038/s41586-022-04865-0. View in: PubMed


Nailing the nuance on COVID-19

Wachter RM. Nailing the nuance on COVID-19. Science. 2022 Jul 15;377(6603):243. [Epub ahead of print]. doi: 10.1126/science.add8599. View in: PubMed


The impact of the COVID-19 pandemic on internet use and use of digital health tools: A secondary analysis of the 2020 health information national trends survey

Zeng B, Rivadeneira NA, Wen A, Sarkar U, Khoong EC. The impact of the COVID-19 pandemic on internet use and use of digital health tools: A secondary analysis of the 2020 health information national trends survey. J Med Internet Res. 2022 Aug 26. [Epub ahead of print]. doi: 10.2196/35828. View in: PubMed